The favorable survival trend was clearer even for positive staining of MAP3K3 in both tumor and lymphocytes versus MAP3K3 negative staining in both samples (Fig. 4K, p = 0.01 for both positive vs. both negative). The gene discussed is MAP3K3; the disease is neoplasm.